
VCs reap 3x return on Dexela sale
Albion Ventures and the London Technology Fund (LTF) have sold UK-based medical equipment company Dexela to US healthcare firm PerkinElmer Inc. for an undisclosed amount.
Albion led a £1.66m series-A round of funding for the company in 2006, contributing £1.2m of equity. Albion and the LTF then led a syndicate of VC backers that invested over £3m in Dexela between July 2008 and January 2009. Overall, Albion has invested £2.6m in the business since 2006.
Investors in Dexela expect to make up to 3x return on their investment. Under their ownership, Dexela purchased Aviex LLC in 2008, a company that designs and builds high-performance X-ray detectors for scientific applications.
Company
Founded in 2005, Dexela specialises in the commercialisation of tomosynthesis for breast cancer screening and other low dose medical x-ray imaging applications.
People
Andrew Elder led the deal for Albion Ventures. The LTF was represented by David McMeekin.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater